Open Nutrition Journal Reports EpiCor to Support Red Blood Cell Health, Mucosal Immune Protection

Embria(R) Health Sciences announced today that its immune-balancing supplement EpiCor(R) supports the formation of healthy red blood cells, supports and protects mucosal immune health and provides anti-inflammatory support, according to a study published in the most recent issue of the peer- reviewed publication, The Open Nutrition Journal.

The double-blind, placebo-controlled, randomized pilot study examined EpiCor's beneficial effects on the immune systems of a group of healthy participants. Specifically, the study found EpiCor to:
-- increase hematocrit, which supports red blood cells;
-- increase secretory IgA, which supports mucosal defense;
-- decrease serum IgE, which supports appropriate immune response;
-- decrease cytokine IL-10, which also supports appropriate immune response; and
-- decrease the overall number of minor health complaints.
Based on these findings, potential future studies on chronically inflamed individuals - such as patients with chronic fatigue syndrome or cardiovascular disease - would be merited.

About EpiCor:
EpiCor is an all-natural, high-metabolite immunogen designed to modulate and balance the human immune system. This dried, complex fermentation product is derived from a proprietary process consisting of Saccharomyces cerevisiae and the medium in which it is grown and is composed of metabolites, vitamins, minerals, amino acids and antioxidants. Recent studies show EpiCor to possess significant anti- inflammatory activity and activate crucial defense cells (Natural Killer, T-, and B-cells). Researched to be safe for ongoing use, EpiCor has achieved self-affirmed GRAS status from an expert panel comprised of members with extensive Food and Drug Administration (FDA), Environmental Protection Agency (EPA) and National Institute of Health (NIH) experience. Research on EpiCor has been presented at the Federation of American Societies for Experimental Biology (FASEB) Conference and the American College of Nutrition (ACN) Symposium.
Clinical trials with EpiCor have been published in Urologic Nursing and The Open Nutrition Journal.

For more information on EpiCor, visit For an abstract of this study, please contact Amanda Holty at 801.538.0777 or [email protected] .

Jensen, G. et al. A double-blind, placebo-controlled, randomized pilot
study: Consumption of a high-metabolite immunogen from yeast culture has beneficial effects on erythrocyte health and mucosal immune protection in healthy subjects. The Open Nutrition Journal (2008), vol. 2, pp. 68-75.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.